Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
about
Interferon Gamma Release Assays for Latent Tuberculosis: What Are the Sources of Variability?Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers.Performance of Interferon-Gamma and IP-10 Release Assays for Diagnosing Latent Tuberculosis Infections in Patients with Concurrent Malaria in TanzaniaAntigen-Specific IFN-γ Responses Correlate with the Activity of M. tuberculosis Infection but Are Not Associated with the Severity of Tuberculosis Disease.QFT-Plus: a plus in variability? - Evaluation of new generation IGRA in serial testing of students with a migration background in GermanyClinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6.Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection.New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets?Impact of correcting the lymphocyte count to improve the sensitivity of TB antigen-specific peripheral blood-based quantitative T cell assays (T-SPOT.(®)TB and QFT-GIT).Diagnostic Utility of New Equation for Active Tuberculosis Based on Parameters of Interferon-γ Release Assay.Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.Repeatability of QuantiFERON-TB gold in-tube assay results near cut-off points.A borderline range for Quantiferon Gold In-Tube results.QuantiFERON-plus does not discriminate between active and latent tuberculosis.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.The Intention to Test for Latent Tuberculosis Should Be a Targeted Intention to Trust and Treat the Result.Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.Assessment and monitoring of biologic drug adverse events in patients with psoriasis.Effectiveness of control measures to prevent occupational tuberculosis infection in health care workers: a systematic review.IFN-γ Release Assays for Risk Assessment in Contacts of Patients with Tuberculosis in Low-Burden European CountriesBoosting effect of IL-7 in interferon gamma release assays to diagnose Mycobacterium tuberculosis infection
P2860
Q28077178-4D126E8E-7E67-42A9-BB0E-15AABE88ABD8Q34776030-54BDA2EC-783D-4622-BB99-BA8FB922F223Q36776006-AACB2288-74A9-4C5C-89D4-A70CECDE7A1BQ37500859-5CB7D32F-E1E9-407D-9CE4-F629BFED089BQ37563933-0DD9935A-98D1-4DC4-BB96-A0CFC4245F94Q37649784-2524FD07-A9B7-43A3-8DB5-595D324A818DQ37741088-27312374-9CF5-4F08-AF69-EB63616644F2Q38664922-2474D6B7-485D-406C-A297-AC45411EF7EEQ38829376-98512580-B194-46A0-9D77-7A74C5DBC6EBQ39433439-5965B375-357D-4A25-886B-5DC9ED04A1CEQ40256286-01BEB756-770A-4E64-A2BA-5324FE430241Q40596209-A1A588FD-921F-45E5-9FC5-A4E8F60AEA21Q40877218-329BFDA8-BE64-4D5F-9F51-1522AF504F7CQ40897243-77B408F5-BDF3-48C7-A9AB-179FF6EA718BQ43109576-DB2C4614-7A1D-411C-9AF8-04677E8AEFEEQ47119840-6228B10E-15DC-442F-8E7B-01227D157246Q47656773-CFACCDDB-0C66-4F75-965C-18AB69A8B7FFQ48066031-963210B6-A577-441F-BCDA-89DFA4803063Q53695974-04324A7F-1184-428C-BED5-B1D2D8E1DA71Q53764017-C7B07A4C-EEFA-4CC9-A81C-F2C4F921556DQ54241389-D1B0A008-727A-4244-98C0-D3F89122D294Q55153984-1FD254BD-5BA8-45FF-98B8-CD7AD26FD56BQ55157878-33291798-B4FD-4A29-B067-B92225F76FBBQ56394992-4B38B0B9-2A4B-48AC-8BAD-E28B4CF80C70Q58696258-2C940D05-4008-4B92-82C9-5C12940259CD
P2860
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@ast
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@en
type
label
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@ast
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@en
prefLabel
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@ast
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@en
P2093
P2860
P50
P1476
Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.
@en
P2093
Adithya Cattamanchi
Andrea Benedetti
David Dowdy
John Metcalfe
Madeline Slater
Nandini Dendukuri
Niaz Banaei
Richard van Zyl Smit
Saloua Tagmouti
Sandra V Kik
P2860
P304
P356
10.1513/ANNALSATS.201405-188OC
P577
2014-10-01T00:00:00Z